MHC Class I Chain-Related Gene A Diversity in Head and Neck Squamous Cell Carcinoma

Human Immunology

Volumn 67, Issue 3, 2006, Pages 196-203

  Reinders, Judith ^a   Rozemuller, Erik H ^a   van der Ven, Kevin J W ^a   Caillat Zucman, Sophie ^b   Slootweg, Pieter J ^a   de Weger, Roel A ^a   Tilanus, Marcel G J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

HLA; HNSCC; MICA expression; MICA repeat

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 CHAIN RELATED A; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SHORT TANDEM REPEAT; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TANDEM REPEAT SEQUENCES;

EID: 33646470931     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.02.006     Document Type: Article

References (49)

1. The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 401 6756 (1999) 921
2. Beck S., and Trowsdale J. The human major histocompatability complex. lessons from the DNA sequence. Annu Rev Genomics Hum Genet 1 (2000) 117
3. Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamomlert D.A., and Leversha M. The DNA sequence and analysis of human chromosome 6. Nature 425 6960 (2003) 805
4. Bahram S., Bresnahan M., Geraghty D.E., and Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 91 14 (1994) 6259
5. Bahram S. MIC genes. from genetics to biology. Adv Immunol 76 (2000) 1
6. Li P., Willie S.T., Bauer S., Morris D.L., Spies T., and Strong R.K. Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity 10 5 (1999) 577
7. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., and Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93 22 (1996) 12445
8. Zwirner N.W., Fernandez-Vina M.A., and Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 47 2 (1998) 139
9. Rueda B., Pascual M., Lopez-Nevot M.A., Gonzalez E., and Martin J. A new allele within the transmembrane region of the human MICA gene with seven GCT repeats. Tissue Antigens 60 6 (2002) 526
10. Perez-Rodriguez M., Corell A., Arguello J.R., Cox S.T., Mc Whinnie A., Marsh S.G., and Madrigal J.A. A new MICA allele with ten alanine residues in the exon 5 microsatellite. Tissue Antigens 55 2 (2000) 162
11. Mizuki N., Ota M., Kimura M., Ohno S., Ando H., Katsuyama Y., Yarnazaki M., Watanabe K., Goto K., Nakamura S., Bahram S., and Inoko H. Triplet repeat polymorphism in the transmembrane region of the MICA gene. a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 94 4 (1997) 1298
12. Goto K., Ota M., Ohno S., Mizuki N., Ando H., Katsuyama Y., Maksymowych W.P., Kimura M., Bahram S., and Inoko H. MICA gene and ankylosing spondylitis. linkage analysis via a transmembrane-encoded triplet repeat polymorphism. Tissue Antigens 49 5 (1997) 503
13. Yabuki K., Mizuki N., Ota M., Katsuyama Y., Palimeris G., Stavropoulos C., Koumantaki Y., Spyropoulou M., Giziaki E., Kaklamani V., Kaklamani E., Inoko H., and Ohno S. Association of MICA gene and HLA-B*5101 with Behcet's disease in Greece. Invest Ophthalmol Vis Sci 40 9 (1999) 1921
14. Sugimura K., Ota M., Matsuzawa J., Katsuyama Y., Ishizuka K., Mochizuki T., Mizuki N., Seki S.S., Honma T., Inoko H., and Asakura H. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis. Tissue Antigens 57 1 (2001) 9
15. Choi H.B., Han H., Youn J.I., Kim T.Y., and Kim T.G. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population. Tissue Antigens 56 6 (2000) 548
16. Gonzalez S., Martinez-Borra J., Torre-Alonso J.C., Gonzalez-Roces S., Sanchez del Rio J., Rodriguez Perez A., Brautbar C., and Lopez-Larrea C. The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 42 5 (1999) 1010
17. Chung-Ji L., Yann-Jinn L., Hsin-Fu L., Ching-Wen D., Che-Shoa C., Yi-Shing L., and Kuo-Wei C. The increase in the frequency of MICA gene A6 allele in oral squamous cell carcinoma. J Oral Pathol Med 31 6 (2002) 323
18. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., and Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA 96 12 (1999) 6879
19. Hankey K.G., Drachenberg C.B., Papadimitriou J.C., Klassen D.K., Philosophe B., Bartlett S.T., Groh V., Spies T., and Mann D.L. MIC expression in renal and pancreatic allografts. Transplantation 73 2 (2002) 304
20. Zwirner N.W., Dole K., and Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol 60 4 (1999) 323
21. Pende D., Rivera P., Marcenaro S., Chang C.C., Biassoni R., Conte R., Kubin M., Cosman D., Ferrone S., Moretta L., and Moretta A. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes. analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62 21 (2002) 6178
22. Wagsater D., Dimberg J., Hugander A., Sirsjo A., and Ghaderi M. Analysis of MICA gene transcripts in human rectal cancers. Anticancer Res 23 3B (2003) 2525
23. Vetter C.S., Groh V., thor Straten P., Spies T., Brocker E.B., and Becker J.C. Expression of stress-induced MHC class I related chain molecules on human melanoma. J Invest Dermatol 118 4 (2002) 600
24. Salih H.R., Rammensee H.G., and Steinle A. Cutting edge. down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169 8 (2002) 4098
25. Groh V., Wu J., Yee C., and Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419 6908 (2002) 734
26. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., and Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 5428 (1999) 727
27. Yokoyama W.M. Immunology. catch us if you can. Nature 419 6908 (2002) 679
28. In: Van Dyck J.A.A.M., Coebergh J.W.W., Siesling S., and Visser O. (Eds). Trends of cancer in the Netherlands 1989-1998. Report of the Netherlands Cancer Registry (2002)
29. Barnes L., Everson J., Reichart P., Sidransky D., and World Health Organization. Classification of Tumours. Pathology and Genetics of Tumours of the Head and Neck (2005), IARC Press, Lyon
30. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 3 (1988) 1215.
31. Reinders J., Rozemuller E.H., Ongkosuwito J.V., Jager M.J., Tilanus M.G., and Suttorp-Schulten M.S. MICA association with presumed ocular histoplasmosis syndrome (POHS). Mol Vis 9 (2003) 420
32. Hue S., Monteiro R.C., Berrih-Aknin S., and Caillat-Zucman S. Potential Role of NKG2D/MHC Class I-Related Chain A Interaction in Intrathymic Maturation of Single-Positive CD8 T Cells. J Immunol 171 4 (2003) 1909
33. Svejgaard A., and Ryder L.P. HLA and disease associations. detecting the strongest association. Tissue Antigens 43 1 (1994) 18
34. Kennedy C., Naipal A., Gruis N.A., Struijk L., ter Schegget J., Willemze R., Claas F.H., Bouwes Bavinck J.N., and Doxiadis. MICA gene polymorphism is not associated with an increased risk for skin cancer. II. J Invest Dermatol 118 4 (2002) 686
35. Ghaderi M., Nikitina Zake L., Wallin K., Wiklund F., Hallmans G., Lenner P., Dillner J., and Sanjeevi C.B. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 62 10 (2001) 1153
36. Ghaderi M., Hjelmstrom P., Hallmans G., Wiklund F., Lenner P., Dillner J., and Sanjeevi C.B. MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia. Hum Immunol 60 10 (1999) 970
37. Suemizu H., Radosavljevic M., Kimura M., Sadahiro S., Yoshimura S., Bahram S., and Inoko H. A basolateral sorting motif in the MICA cytoplasmic tail. Proc Natl Acad Sci USA 99 5 (2002) 2971
38. Tian W., Boggs D.A., Ding W.Z., Chen D.F., and Fraser P.A. MICA genetic polymorphism and linkage disequilibrium with HLA-B in 29 African-American families. Immunogenetics 53 9 (2001) 724
39. Visser C.J., Tilanus M.G., Tatari Z., van der Zwan A.W., Bakker R., Rozemuller E.H., Schaeffer V., Tamouza R., and Charron D. Sequencing-based typing of MICA reveals 33 alleles. a study on linkage with classical HLA genes. Immunogenetics 49 6 (1999) 561
40. Petersdorf E.W., Shuler K.B., Longton G.M., Spies T., and Hansen J.A. Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics 49 7-8 (1999) 605
41. Yao Z., Volgger A., Helmberg W., Keller E., Fan L.A., Chandanayingyong D., and Albert E.D. Definition of new alleles of MIC-A using sequencing-based typing. Eur J Immunogenet 26 2-3 (1999) 225
42. Fodil N., Pellet P., Laloux L., Hauptmann G., Theodorou I., and Bahram S. MICA haplotypic diversity. Immunogenetics 49 6 (1999) 557
43. Lu C.C., Chen J.C., Jin Y.T., Yang H.B., Chan S.H., and Tsai S.T. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer 103 6 (2003) 745
44. Hildesheim A., Apple R.J., Chen C.J., Wang S.S., Cheng Y.J., Klitz W., Mack S.J., Chen I.H., Hsu M.M., Yang C.S., Brinton L.A., Levine P.H., and Erlich H.A. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 94 23 (2002) 1780
45. Goldsmith D.B., West T.M., and Morton R. HLA associations with nasopharyngeal carcinoma in Southern Chinese. a meta-analysis. Clin Otolaryngol 27 1 (2002) 61
46. Dardari R., Khyatti M., Jouhadi H., Benider A., Ettayebi H., Kahlain A., Mansouri A., El Gueddari B., and Benslimane A. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 92 2 (2001) 294
47. Koene G., van der Ven K., Verdaasdonk M., Slootweg P., de Weger R., and Tilanus M. A variety of HLA phenotypes in head and neck squamous cell carcinoma patients identified with the workshop antibodies as defined in the HLA and cancer component. In: Dupont B., and Hansen J. (Eds). HLA 2004. Immunobiology of the human MHC vol I & II (2004), IHWG Press, Seattle, WA Proceedings of the 13th International Histocompatibility Workshop and Congress
48. Bauernhofer T., Kuss I., Henderson B., Baum A.S., and Whiteside T.L. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. Eur J Immunol 33 1 (2003) 119
49. Melioli G., Semino C., Margarino G., Mereu P., Scala M., Cangemi G., Crocetti E., Machi A.M., and Ferlazzo G. Expansion of natural killer cells in patients with head and neck cancer. Detection of "noninhibitory" (activating) killer Ig-like receptors on circulating natural killer cells. Head Neck 25 4 (2003) 297